Literature DB >> 1797943

Regional variation in adipose tissue lipolysis in lean and obese men.

P Mauriège1, J P Després, D Prud'homme, M C Pouliot, M Marcotte, A Tremblay, C Bouchard.   

Abstract

Biopsies of adipose tissue were obtained from two subcutaneous regions (abdominal and femoral) in a sample of 54 men (32 obese and 22 lean subjects). Clonidine-induced antilipolysis in femoral adipose cells was similar in both groups, whereas subcutaneous abdominal adipocytes of obese individuals showed a higher alpha 2-adrenergic response than did subcutaneous abdominal adipose cells from lean subjects. In addition, epinephrine had a biphasic effect in subcutaneous abdominal adipocytes from obese individuals, as it induced antilipolysis at low concentrations, and a net lipolytic response at higher doses. In contrast, the physiological amine promoted lipolysis in subcutaneous abdominal adipose cells of lean subjects. Epinephrine- and clonidine-induced antilipolysis of subcutaneous abdominal adipocytes was positively associated with the level of subcutaneous abdominal fat measured by computed tomography (CT). Finally, men with a high alpha 2-adrenergic response of subcutaneous abdominal fat cells were fatter than those with a low alpha 2-adrenergic component. These results suggest that, in men with a wide range of body fatness, variations in the lipolytic response of subcutaneous abdominal adipose cells to epinephrine appear to involve changes in the functional balance between alpha 2- and beta-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797943

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

Review 1.  The effects of exercise training on fat-mass loss in obese patients during energy intake restriction.

Authors:  Dominique Hansen; Paul Dendale; Jan Berger; Luc J C van Loon; Romain Meeusen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 2.  Adrenoceptors in white, brown, and brite adipocytes.

Authors:  Bronwyn A Evans; Jon Merlin; Tore Bengtsson; Dana S Hutchinson
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

3.  In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity.

Authors:  P Bougnères; C L Stunff; C Pecqueur; E Pinglier; P Adnot; D Ricquier
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

4.  Contributions of white and brown adipose tissues and skeletal muscles to acute cold-induced metabolic responses in healthy men.

Authors:  Denis P Blondin; Sébastien M Labbé; Serge Phoenix; Brigitte Guérin; Éric E Turcotte; Denis Richard; André C Carpentier; François Haman
Journal:  J Physiol       Date:  2014-12-15       Impact factor: 5.182

5.  Characterisation of insulin-resistant phenotype of cultured rat primary adipose cells.

Authors:  C C Xiang; Y J Wu; L Ma; L Ding; I Lisinski; M J Brownstein; S W Cushman; X Chen
Journal:  Diabetologia       Date:  2007-03-23       Impact factor: 10.122

Review 6.  Catecholamines and obesity: effects of exercise and training.

Authors:  Hassane Zouhal; Sophie Lemoine-Morel; Marie-Eve Mathieu; Gretchen A Casazza; Georges Jabbour
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

7.  Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.

Authors:  S Reynisdottir; K Ellerfeldt; H Wahrenberg; H Lithell; P Arner
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.

Authors:  F Lönnqvist; H Wahrenberg; L Hellström; S Reynisdottir; P Arner
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.

Authors:  L Hellström; D Langin; S Reynisdottir; M Dauzats; P Arner
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

10.  Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.

Authors:  S Reynisdottir; H Wahrenberg; K Carlström; S Rössner; P Arner
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.